DNA Authentication of Plantago Herb Based on Nucleotide Sequences of 18S-28S rRNA Internal Transcribed Spacer Region
1F and 1R) were designed based on the rRNA gene sequence of P. major retrieved from the DDBJ/EMBL/Genbank Nucleotide Sequence Database (accession no. AY101861). PlarDNA 1F and Pla-rDNA 1R were designed to anneal to the 3Ј-end of 18S rRNA gene and 5Ј-end of 28S rRNA gene, respectively. For some samples it was difficult to amplify the whole ITS region. In such cases internal primers Pla-rDNA 2F and Pla-rDNA 2R annealing to 5Ј-end and 3Ј-end, respectively, of 5.8S rRNA gene were used for PCR. Annealing positions of these PCR primers are shown in Fig. 1 . Nucleotide sequences of the primers were as follows: Pla-rDNA 1Fϭ5Ј-GTTTTCCCAGTCACGACCAAGGTTTCCGTAGGTGA-AC, Pla-rDNA 1Rϭ5Ј-ATTTAGGTGACACTATAGAATAC-GATATGCTTAAACTCAGCGG, Pla-rDNA 2Fϭ5Ј-GTT-TTCCCAGTCACGACCGTAGCGAAATGCGATAC, PlarDNA 2Rϭ5Ј-ATTTAGGTGACACTATAGAATACGGGCG-CAACTTGCGTTCAAA. The underlined sequence in the forward and reverse primers shows the M13 universal forward primer and SP6 primer sequence, respectively, for direct sequencing of the PCR products. PCR amplification was carried out in a 25 ml reaction mixture consisting of 10 mM Tris-HCl (pH 8.8), 25 mM potassium chloride, 5 mM ammonium sulfate, 2 mM magnesium sulfate, 0.2 mM each dNTP, 0.4 mM of each primer, 0.4 ng/ml template DNA and 0.02 unit/ml Taq DNA Polymerase (Roche). Amplification was carried out under the following conditions: precycling at 94°C for 3 min, 30 cycles of denaturation at 94°C for 30 s, annealing at 55°C for 30 s and elongation at 72°C for 1 min, and then final elongation at 72°C for 5 min. PCR products were detected by ethidium bromide staining following 2% agarose gel electrophoresis using 5 ml of the PCR mixture.
Sequencing of the PCR Products Usually a 10 ml aliquot of the PCR mixture was incubated with 5 ml of ExoSAP-IT solution (GE Healthcare Bio-Sciences) at 37°C for 15 min and then at 80°C for 15 min. A 7 ml aliquot of the resulting mixture was used for sequencing reaction using Thermo Sequenase Primer Cycle Sequencing Kit (GE Healthcare Bio-Sciences) and the nucleotide sequence was determined for both strands with DSQ-2000L (Shimadzu).
Phylogenetic Analysis DNA sequences of the ITS locus were aligned using the Clustal X program.
15) The genetic distances were computed by Kimura's two-parameter method, 16) and the phylogenetic tree was constructed by the NeighborJoining method in the PHYLIP software package (Felsenstein J., Phylogeny Inference Package, version 3.5C, University of Washington, Seattle, U.S.A.). The tree was evaluated using the bootstrap test 17) based on 1000 resamplings. TLC Analysis Powdered crude drug (about 2 g) was briefly refluxed in 10 ml methanol and filtered. A 10 ml aliquot of the filtrate was applied to a silica gel plate which was developed with n-butanol-water-acetic acid (7 : 2 : 1) and plantamajoside was detected by spraying 9% ferric chloride solution.
HPLC Analysis Powdered crude drug (about 100 mg) was sonicated in 5 ml of 70% methanol for 30 min at room temperature and filtered. A 10 ml aliquot of the filtrate was applied to HPLC column (Unisil QC18, 5 mm, 4.6ϫ250 mm, GL Sciences) with isocratic elution by methanol-2% acetic acid (35 : 65). The flow rate was 1.5 ml/min and the elution was monitored at 330 nm. The HPLC conditions are identical with those reported in ref. 12 .
RESULTS AND DISCUSSION

Sequence Analysis of the ITS Region Amplified from
Medicinal Plantago Species PCR products containing ITS1, 5.8S rDNA and ITS2 were amplified from all the samples of fresh plants and some herbarium specimens using a PCR primer set (Pla-rDNA 1F and Pla-rDNA 1R) designed 1266 Vol. 30, No. 7 based on the rDNA sequence of Plantago major retrieved from the DNA databank, and their nucleotide sequences were determined. In some herbarium samples, DNA was highly degraded into small fragments and did not give a PCR product when DNA preparations from these samples were used as templates. In such cases ITS1 and ITS2 were separately amplified using internal primers annealing to 5Ј-and 3Ј-end of 5.8S rDNA as shown in Fig. 1 . The PCR products were directly applied to sequence reaction following treatment with endonuclease/alkaline phosphatase and their nucleotide sequences were determined. The size of the ITS1 and ITS2 region was about 220 bp and 190 bp, respectively, varying depending on the species. The size of the 5.8S rDNA was 163 bp, irrespective of species. The nucleotide sequence of the ITS regions of P. lanceolata was quite different from other Plantago species examined in the present investigation. Among 21 plants belonging to seven other Plantago species, 44 nucleotide substitutions and four insertions/deletions were recognized. The variable positions are summarized in Table 2 . Based on differences in these sites 11 sequence types were recognized. All the plant samples of P. asiatica collected in Japan exhibited type A1 whereas two P. asiatica plants collected in Taiwan and China revealed type A2. The nucleotide sequence of type A1 is completely identical with the sequence of P. asiatica var. densiuscula collected from various habitats in Japan.
18) The A2 sequence is consistent with that reported for P. asiatica collected in Southeast Asia. 19) Two plant samples of P. major exhibited genotype M1 and one P. major sample from China genotype M2. Three different genotypes were recognized among the P. depressa samples ( Table 3) .
The phylogenetic tree based on the approximately 0.6 kb sequences of the ITS locus showed that P. asiatica, P. hostifolia, P. major and P. erosa are closely related and P. depressa and P. camtschatica form another cluster (Fig. 2) .
ITS-Sequence Based Authentication of Plantago Herb Obtained in the Market
We have amplified the ITS regions from the crude drugs obtained in the Chinese and Japanese markets and determined their nucleotide sequences (Table 4) . Of 29 samples of plantago herb, 10 specimens were from Japan and 19 were from China. All of the crude drugs obtained in Japan exhibited type A1 sequence and were, therefore, identified as P. asiatica. Of the crude drugs obtained in Chinese markets, one sample (ShaToc 21) showed type A1 and seven type A2; these were also identified to be P. asiatica. Three samples were estimated to be P. deprssea with type D1 sequence. There were also two samples having type M2 (P. major) sequence. This is consistent 
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Type V * G * C T * * * G * * * * * * A * * A A G ---* * * C A * * * C C * C C --* * C * * * * * * C An asterisk indicates the base same asin Type A1 and a hyphon reveals an deletion. The ITS sequence of Type L is quite different from other sequence types and, therefore, not included in the table. with the result that a herbarium specimen of P. major collected in Japan exhibited type M1 while two P. major specimens collected in China type M2 (Table 3) . Finally six crude drug samples showed type E (P. erosa) sequence. It is interesting to note that in one sample from Shaanxi (ShaToc8) two signals with similar intensities were detected at all the plolymorphic sites between type A2 and type M2 (68CT, 84AG, 87CT, 537CT), and this sample was assumed to be derived from a hybrid plant between P. asiatica and P. major. This is the first result suggesting the presence of the hybridderived Plantago Herb in the markets. Phenotypic Evaluation of the Crude Drugs Twenty crude drug samples were subjected to morphological and chemical evaluation and the results were compared with those obtained by DNA sequencing (Table 5) . It has been reported that Plantago Herb could be identified based on various morphological and anatomical characteristics such as presence of tap roots, 8) number of midveins, 9) presence of collenchyma cells in the leaf margin 9) and of non-glandular hair.
10) However, we found no correlation between these anatomical traits and original species of the crude drug estimated by DNA authentication (data not shown) except that all the P. depressa-derived crude drug samples (ShaToc20, 22, 26) had tap roots. Detection of a spot corresponding to plantamajoside by TLC has been used as an identification test for Plantago Herb in the Japanese Pharmacopoeia. 4) However, two crude drug samples identified as P. erosa (ShaToc5, 19) gave a positive result by this test while no plantamajoside spot could be detected in one of the P. asiatica-derived samples with genotype A2 (ShaToc25). The tree was constructed by Neighbor-Joining method based on the genetic distances calculated using Kimura's two-parameter method. Applying other tree-constructing algorithms such as UPGMA and parsimony methods gave essentially the same topology. The branch length does not reflect genetic difference between two genotypes. The tree is rooted using the genotype L as the outgroup. Values above the branches indicate percent of the bootstrap confidence level from 1000 resamplings. Noro et al. 12) analyzed composition of phenylethanoid glycosides in Plantago species by HPLC and described that those species with fibrous roots such as P. asiatica, P. major and P. hostifolia contained plantamajoside as a major phenylethanoid while those having tap roots including P. depressa, P. camtschatica and P. lanceolata contained mainly acteoside; these two groups could be discrimiated by the HPLC profile. As shown in Fig. 3 , all the P. depressa-derived crude drug samples (ShaToc20, 22, 26) revealed a typical HPLC pattern with a major peak corresponding to acteoside (profile III) whereas P. asiatica-derived crude drugs with the sequence type A1 (ShaToc7, 15, 21, 29) and two P. major-derived crude drug samples (ShaToc23, 28) exhibited a typical profile (Ia) with a main peak corresponding to plantamajoside. These results are consistent with those reported previouly. 12) Of five samples identified as P. erosa, three (ShaToc5, 18, 19) exhibited an intermediate HPLC profile (profile II) in which both plantamajoside and acteoside are detected in a similar ratio and one (ShaToc16) profile III. Another P. erosa sample (ShaToc17) contained a very low amount of plantamajoside and its HPLC pattern (Profile Ib) is quite similar to that of one P. asiatica-derived crude drug with the sequence type A2 (ShaToc25).
These results indicate that unambiguous discrimination of P. asiatica-derived crude drugs from those of P. major or P. erosa origin is difficult based on morphological and chemical evaluation, although identification of Plantago Herb of P. depressa origin is possible based on the presence of tap roots and the HPLC profile with a major peak corresponding to acteoside.
In conclusion, the present investigation shows that Plantago Herb obtained in the Chinese markets are derived not only from P. asiatica or P. depressa but also from P. major or NAϭdata not available because crude drug sample is either cut into small pieces or lack in underground parts. b) Iaϭplatomajoside was detected as a major peak; Ibϭsimilar to A-I but plantamajoside peak is very small; IIϭplantmajoside and acteoside are detected in similar ratio; IIIϭacteoside is detected as a major peak. 12) For the sample IDs see Table 5 .
